#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ductal adenocarcinoma of pancreas Cerebral amyloid angiopathy Optic ischaemic neuropathy Oesophageal adenocarcinoma stage II Testicular leiomyosarcoma Synovial sarcoma Glycogen storage disease type I Anti-myelin-associated glycoprotein antibodies positive Undifferentiated sarcoma Adrenocortical carcinoma Renal transplant Anti-myelin-associated glycoprotein associated polyneuropathy Glomerulonephritis chronic Hypochromic anaemia Oesophageal atresia More trials…

    Learn about Rare Diseases

    Lymphangioma – Basic Information Krabbe’s disease – Life with Disease Medulloblastoma – Diagnostics Marginal zone lymphoma refractory – Basic Information Activated PI3 kinase delta syndrome Undifferentiated sarcoma – Basic Information Rett syndrome – Treatment Chondrosarcoma – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Basic Information Angiosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imatinib Ganirelix Radium Ra 223 Dichloride SULBACTAM SODIUM TORASEMIDE Mk-1200 GSKVX000000070965 SEPOFARSEN IHMA-2121771-1 Tilmanocept 19Cp02 Felzartamab Tominersen Chlorpromazine Hydrochloride Glucocorticoids Dutasteride Anhydrous Cyclophosphamide ANXV Siponimod Retinol Acetate More therapies…

    Learn about Your Condition

    Endocarditis Leukaemia Prostate cancer recurrent Dizziness Escherichia infection Indolent systemic mastocytosis Chondrosarcoma Pruritus Hypothyroidism Menopause Crohn's disease Implantation complication Pseudomyxoma peritonei Biotinidase deficiency Endometrial cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

P. O. Box 100, Tromsø, 9038, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of UV1 Vaccine with or without Sargramostim for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Non-small cell lung cancer
    Investigated Drugs:
    • Alrefimotide
    • Tapderimotide
    • Sargramostim
    Norway

  • Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Denmark Finland France +7

  • Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Bevacizumab
    • Paclitaxel
    Belgium Denmark Finland France Germany Ireland +4

  • Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Indometacin Ph. Eur.
    • Mercaptopurine Monohydrate
    • Alemtuzumab
    Austria Belgium Czechia Denmark Greece Ireland +6

  • Study on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Hyoscine Butylbromide
    • Sodium Chloride
    • Sodium Hydrogen Carbonate
    Norway

  • Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Atezolizumab
    Denmark Lithuania The Netherlands Norway Sweden

  • Study on Cyclophosphamide for Patients with Advanced Breast Cancer with TP53 Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • Cyclophosphamide
    Norway

  • Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    France Germany Italy Norway Spain Sweden

  • Study on Ticagrelor and Acetylsalicylic Acid for Patients with Acute Coronary Syndrome Undergoing Coronary Artery Bypass Grafting

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    Denmark Finland Iceland Norway Sweden

  • Study on Paracetamol and Strong Opioids for Pain Relief in Patients with Metastatic Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cancer pain
    • Metastatic neoplasm
    Investigated Drugs:
    • Placebo
    • Paracetamol
    Norway
Previous Page
1 … 10 11 12 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!